Market Research Logo

Global DNA Sequencing Products Market 2016-2020

About the DNA Sequencing Products Market

DNA sequencing is categorized into first-generation, second- and next-generation, and emerging technologies. Emerging DNA sequencing technologies are cost-effective and offer more rapid and accurate results than other generation technologies. These technologies find application in the areas of diagnostics, drug and biomarker discovery, personalized medicine, and agriculture and animal research. Since its introduction in 2010, next-generation DNA sequencing has developed rapidly. It offers insights into various areas of science, particularly healthcare and genomic research. However, available DNA sequencing technologies create significant financial complications for laboratories, increasing the pressure on maintaining the expenses for biomedical research. This has increased the demand for less expensive instruments and the need for cost-effective procedures. It has also increased the emphasis on enhancing aspects of sample preparation and expanding the simplicity of the work process for greater proficiency.

Technavio’s analysts forecast the global DNA sequencing products market to grow at a CAGR of 18.75% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global DNA sequencing products market for 2016-2020. To calculate the market size, we consider revenue generated from the sale of equipment, reagents, and consumables used in DNA sequencing.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global DNA Sequencing Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Illumina
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Pacific Biosciences
Other prominent vendors
  • AC-Gen Reading Life
  • Agilent Technologies
  • Beckman Coulter
  • Cofactor Genomics
  • DNA Link
  • Eurofins MWG Operon
  • Expression Analysis
  • GE HealthCare
  • Ototgenetics
  • Oxford Nanopore
Market driver
  • Development of rapid sequencing platforms
  • For a full, detailed list, view our report
Market challenge
  • Limitations of DNA sequencing technology
  • For a full, detailed list, view our report
Market trend
  • Advances in personalized medicine
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global DNA Sequencing Products Market 2016-2020

Technavio recognizes the following companies as the key players in the global DNA sequencing products market: Illumina, Thermo Fisher Scientific, Roche Diagnostics, and Pacific Biosciences.

Other Prominent Vendors in the market are: AC-Gen Reading Life, Agilent Technologies, Beckman Coulter, Cofactor Genomics, DNA Link, Eurofins MWG Operon, Expression Analysis, GE HealthCare, Otogenetics, and Oxford Nanopore.

Commenting on the report, an analyst from Technavio’s team said: “One trend that is expected to boost market growth in a big way is the advances in personalized medicine. Many medical facilities in developed countries and a few in developing countries are implementing DNA sequencing technologies in medical treatment. These facilities use sophisticated technologies and tools such as rapid DNA sequencer for large-scale and quantitative assessments of genomic sequences. These devices have helped make important research discoveries in the area of biomedical sciences. These research results are implemented in clinical settings, particularly in oncology, for the development of personalized medicine.”

According to the report, a key growth driver is the development of rapid sequencing platforms. DNA sequencing has a wide scope in medical diagnosis and personalized treatment options. Sanger and Gilbert methods are first-generation sequencing procedures that were previously used by researchers for genome mapping. Advances in this technology led to the development of second-generation sequencing methods such as pyrosequencing. Further advances led to the development of next-generation sequencing procedures such as Illumina sequencing and 454 sequencing methods. These methods involve the use of advanced technologies, leading to their wide use in various clinical areas.

Further, the report states that one challenge that could hamper market growth is the limitations of DNA sequencing technologies.



Companies Mentioned

Illumina, Thermo Fisher Scientific, Roche Diagnostics, Pacific Biosciences, AC-Gen Reading Life, Agilent Technologies, Beckman Coulter, Cofactor Genomics, DNA Link, Eurofins MWG Operon, Expression Analysis, GE HealthCare, Otogenetics, Oxford Nanopore.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Cost per genome 2001-2014
      • Table Cost per megabase of DNA sequence 2001-2014
    • Benchmark for sequencing companies
      • Table Cost of next-generation sequencing platforms
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global DNA sequencing products market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Types of equencing echnology platforms
    • Table Types of sequencing platforms
    • Illumina synthesis
    • Ion semiconductor sequencing
    • Sequencing by ligation
    • Pyrosequencing
    • Single molecule, real-time (SMRT) sequencing
  • Reimbursement and coverage
    • Payer perspective: Validating next-generation sequencing
    • Coding
    • Challenge for payers in US
    • Next-generation tumor sequencing
    • Conclusion
  • Regulation of next-generation sequencing tests in US
    • Analytical performance of next-generation sequencing tests
    • Assessing clinical performance of next-generation sequencing tests
  • Market segmentation by product
    • Table Global DNA sequencing products market segmentation by product 2015
    • Global DNA sequencing products market for reagents and consumables
      • Table Global DNA sequencing products market for reagents and consumables 2015-2020 ($ billions)
    • Global DNA sequencing products market for equipment
      • Table Global DNA sequencing products market for equipment 2015-2020 ($ billions)
  • Market segmentation by end-user
    • Table Global DNA sequencing products market segmentation by end-user 2015
  • Geographical segmentation
    • Table Global DNA sequencing products market segmentation by geography 2015
    • Table Global DNA sequencing products market segmentation by geography 2020
    • Table Global DNA sequencing products market segmentation by geography 2015-2020
    • DNA sequencing products market in Americas
      • Table DNA sequencing products market in Americas 2015-2020 ($ billions)
    • DNA sequencing products market in EMEA
      • Table DNA sequencing products market in EMEA 2015-2020 ($ billions)
    • DNA sequencing products market in APAC
      • Table DNA sequencing products market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Understanding of human genomics
    • Development of rapid sequencing platforms
    • Decline in DNA sequencing costs
    • Incidence of chronic diseases
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Limitations of DNA sequencing technology
    • Unfavorable reimbursement scenario
    • Limited skilled medical professionals
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increase in partnerships and collaborations
    • Advances in personalized medicine
    • Focus on bioinformatics
  • Vendor landscape
    • Competitive scenario
    • Key news
    • Market share analysis 2015
      • Table Market share of vendors 2015
    • Illumina
      • Table Illumina: Product portfolio
      • Table Illumina: Key takeaways
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Product portfolio
      • Table Thermo Fisher Scientific: Key takeaways
    • Roche Diagnostics
      • Table Roche Diagnostics: Product portfolio
      • Table Roche Diagnostics: Key takeaways
    • Pacific Biosciences
      • Table Pacific Biosciences: Key takeaways
    • Other prominent vendors
      • Table Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report